Bringing you a curated selection of podcasts relating to COVID-19 across The BMJ, our specialist journals and Best Practice. 
The purpose of these podcasts is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

BMJ's Coronavirus (COVID-19) playlist

Thousands of people are currently being vaccinated against COVID-19 worldwide. In this podcast, we discuss if the authorised vaccines are useful to people who live with HIV.
STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Editor in Chief of the STI Journal; Dr Laura Waters, Sexual Health and HIV specialist at The Mortimer Market Centre, London, and chair of BHIVA; and Mr Simon Collins, HIV patient advocate and editor of the HIV Treatment Bulletin at the i-Base.
Read the related blog post: https://blogs.bmj.com/sti/2021/04/23/2021episode3/
Related article: https://www.bhiva.org/SARS-CoV-2-vaccine-advice-for-adults-living-with-HIV-plain-english-version-update

COVID-19 Vaccine and People who live with HIV

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Dr Tariq Ahmad and Dr Nick Kennedy, both from the Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, UK. 
This special Gut podcast is focused on ‘Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab’ which is published in paper copy in Gut in May 2021 and the recently published paper ‘Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines’. 
Acknowledgements: The CLARITY IBD team would like to thank the CLARITY IBD team in Exeter, all of the 92 CLARITY IBD sites and over 7000 participants in the study. We are grateful to support from the NIHR CRN, Crohn's & Colitis UK and our funders.
The related links:
https://gut.bmj.com/content/early/2021/04/25/gutjnl-2021-324789
https://gut.bmj.com/content/70/5/865

CLARITY IBD: Anti-SARS-CoV-2 antibody and vaccination responses in patients treated with infliximab

David Perry is a freelance journalist covering politics, history, education, and disability rights with bylines at CNN, NYT, Atlantic, Guardian and many more. He and his food-scientist wife live in the Twin Cities with their children, one of whom has Down syndrome, and Perry also plays in an Irish rock band. 
Today on the podcast, David talks about access and education under COVID-19. What does it mean to really provide free and fair education to all? 
Read the related blog post, which includes the transcript of this podcast:
https://blogs.bmj.com/medical-humanities/2021/05/12/generation-covid-education-access-and-the-long-shadow-of-pandemic-trauma

Generation Covid: Education, Access, and the Long Shadow of Pandemic Trauma

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Dr Ryan Ungaro, who is an Assistant Professor at Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA. The podcast is focussed on ‘Effect of IBD medications on COVID-19 outcomes: results from an international registry’ published in paper copy in Gut in April 2021.
Related or relevant article: https://gut.bmj.com/content/70/4/725

Effect of IBD medications on COVID-19 outcomes

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19.

Emma Scott, section editor, updates us on vaccination for pregnant and breastfeeding women.

And Abigail Davis, GP and section editor, covers myocardial infarction and pre-existing respiratory conditions.

For more, see:

BMJ Best Practice's topic on covid-19: bestpractice.bmj.com/topics/en-gb/3000168

BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): new-learning.bmj.com/course/10065100

BMJ Learning covid-19 in primary care module: new-learning.bmj.com/course/10065230

Covid-19: Vaccination in pregnancy, myocardial infarction, and respiratory conditions

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) review the June issue of DTB. 
The list of articles mentioned in this podcast:
The Editorial “COVID-19 vaccination in pregnancy” - https://dtb.bmj.com/content/59/6/82
DTB select “Stepping down asthma treatment” - https://dtb.bmj.com/content/59/6/85
Review “Prescribing for pregnancy: managing diabetes” - https://dtb.bmj.com/content/59/6/88
Republished case report “Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin)” - https://dtb.bmj.com/content/59/6/93
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.

June 2021 - COVID-19 vaccination in pregnancy

The Oxford Astra Zeneca vaccine has been associated with a rare complication of cerebral venous sinus thrombosis. Dr Colin Mahoney, JNNP Podcast Editor, interviews Prof David Werring, Professor of Clinical Neurology, UCL Queen Square Institute of Neurology, UK, about the new evidence which supports an association between vaccination and more common large vessel arterial stroke. They also discuss several cases, including treatment, and emerging biological evidence relating to causation.  
Read the paper "Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia", on the JNNP website: https://jnnp.bmj.com/content/early/2021/05/20/jnnp-2021-326984.
Related editorial paper: https://jnnp.bmj.com/content/early/2021/05/20/jnnp-2021-327057

COVID - 19 Vaccination and risk of large vessel arterial stroke

Medical Humanities' Editor-in-Chief, Brandy Schillace, talks to Dr. Eleanor Janega, a medieval historian, about comparisons between COVID-19 and the Black Death.
Read the blog post, which includes the transcript of the podcast, here: https://blogs.bmj.com/medical-humanities/2021/07/15/going-medieval-historical-comparisons-of-plague-and-pandemic/

Going Medieval: Historical Comparisons of Plague and Pandemic

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to Covid-19.

Abigail Davis, GP and section editor, covers the latest evidence around vaccine immunogenicity in different immunosuppressed populations, as well as the use of interleukin-6 inhibitors in COVID-19 patients.

And Emma Scott, section editor, updates us on mucormycosis, or black fungus infection in COVID-19 patients.

For more, see:

BMJ Best Practice's topic on COVID-19: bestpractice.bmj.com/topics/en-gb/3000168

BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): new-learning.bmj.com/course/10065100

BMJ Learning COVID-19 in primary care module: new-learning.bmj.com/course/10065230

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00676-0/fulltext

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2100433

WHO Therapeutics and COVID-19: living guideline: https://app.magicapp.org/#/guideline/nBkO1E/section/LrV7OL

Indian Council of Medical Research advice on mucormycosis: https://www.icmr.gov.in/pdf/covid/techdoc/Mucormycosis_ADVISORY_FROM_ICMR_In_COVID19_time.pdf

COVID-19: Vaccine immunogenicity, interleukin-6 inhibitors, mucormycosis

In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies. 
Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future.
Related content: 
https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272
https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

An outlook at how disabled lives have been affected by the COVID-19 pandemic and, in particular, by the current vaccine roll-out. Alice Wong, a disabled activist, and Alyssa Burgart, an anesthesiologist and ethicist at Stanford University, tell Medical Humanities' Editor-in-Chief, Brandy Schillace, how disabled lives have been overlooked in this crisis, as the very systems and designs of medicine cater to the able-bodied. 
Read the transcript on the Medical Humanities blog (https://blogs.bmj.com/medical-humanities/2021/08/12/medicines-disability-blind-spot-privilege-access-and-the-continued-vaccine-roll-out).
You can subscribe to the Medical Humanities podcast on any of the main platforms to get the latest episodes. If you enjoy the show, please consider leaving us a review or a comment on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you.

Medicine’s Disability Blind Spot: Vaccine Roll-out, Privilege, and Access

This week our regular panelists, Helen Macdonald and Joe Ross, are joined by Juan Franco, editor in chief of BMJ Evidence Based Medicine - to take a primary care focussed look at what's been happening in the world of evidence.

On this week’s episode. 
As kids go back to school, winter bugs surge and pressure mounts on health services we look at two trials which aimed to use reduce antibiotic prescribing for respiratory tract infections in nursing homes and primary care

Juan brings us an update on prescribing medicinal cannabis for pain, based on a recent BMJ rapid recommendation article and linked systematic review and meta-analysis

And finally, in covid news, how likely are you to be admitted or die from covid after one or two SARS-CoV 2 vaccinations?

Reading list
Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents - https://www.bmj.com/content/374/bmj.n2198

Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care - https://www.bmj.com/content/374/bmj.n2132

Medical cannabis or cannabinoids for chronic pain - https://www.bmj.com/content/374/bmj.n2040

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination - https://www.bmj.com/content/374/bmj.n2244

Talk Evidence - testing for respiratory tract infections, cannabis for pain, & covid outcomes

In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, talks to Dr Ash Clift Nuffield Department of Primary Care Health Sciences, University of Oxford.
The evidence surrounding COVID-19 has been conflicting and inconsistent. This podcast discusses the findings of this observational and Mendelian randomisation study using the UK Biobank cohort. The author discusses the findings with regards to the potential causal effect of cigarette smoking on the severity of COVID-19 infection and what this means for both the public and clinicians.
Related article: https://thorax.bmj.com/content/thoraxjnl/early/2021/09/12/thoraxjnl-2021-217080

Cigarettes and COVID-19: clearing the smoke

In this podcast series, Kamran Abbasi, executive editor of The BMJ will convene experts from South Asia to discuss how the pandemic has affected the region, how measures like lock-down and vaccination have been handled, and the impact of the pandemic on the social determinants of health.

In this first podcast, we're focussing on India and Nepal, and are joined by;

Srinath Reddy, president of the Public Health Foundation of India. 

Biraj Swain, who works in global development in Asia and East Africa, is a senior media critic

and Buddha Basnyat, director of the Oxford University Clinical Research Unit in Nepal. 

For more covid coverage

www.bmj.com/coronavirus

Covid in south Asia - India and Nepal

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Professor Andrew Chan, Harvard Medical School, Boston, USA. This podcast is focused on the paper "Diet quality and risk and severity of COVID-19: a prospective cohort study", published in paper copy in Gut in November 2021. Link to the paper: https://gut.bmj.com/content/70/11/2096

Diet quality and risk and severity of COVID-19: a prospective cohort study

In this episode of the JIM Podcast, Editor-In-Chief Richard McCallum speaks with Dr. Sonja A. Rasmussen on the COVID-19 vaccine in children and pregnancy. Dr. Rasmussen is currently a Tenured Professor at the University of Florida in the Department of Pediatrics with a Joint Appointment at the Department of Epidemiology and Obstetrics and Gynecology. 

She has previously served as Deputy Director of Infectious Disease at the CDC, Acting Director of the Office of Health Preparedness and Response, Deputy Director of the Influenza Coordination Unit and Senior Scientist at the National Center on Birth Defects and Developmental Disabilities.

Covid-19 Vaccine in Children and Pregnancy with Dr. Sonja A. Rasmussen

Do hospitalised COVID-19 patients receiving treatment with CPAP and HFNOT present a significant added risk of viral contamination to the surrounding environment used by healthcare workers?
And is there enough evidence to suggest or recommend levels of PPE that should be used for healthcare workers caring for patients on CPAP or HFNOT?
Two of the main questions this short podcast addresses. Rachael Moses, Multimedia Editor Thorax BMJ, interviews Dr Chris Green, Consultant in Infectious Diseases & General (Internal) Medicine, University Hospitals Birmingham NHS Foundation Trust.
Read the two related papers:
SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures - https://thorax.bmj.com/content/early/2021/11/01/thoraxjnl-2021-218035
Coughs and sneezes spread diseases: but do ‘aerosol generating’ procedures? - https://thorax.bmj.com/content/early/2021/11/10/thoraxjnl-2021-218133

What are the risks from 'aerosol-generating procedures’ in the treatment of patients with COVID-19?

Professor Roszalina Ramli, Department of oral and maxillofacial surgery, Universiti Kebangsaan Malaysia, Kuala Lumpur, is an oral and maxillofacial surgeon by training, who developed skills in biomechanics and epidemiology in order to solve what she saw as a major community problem. In this podcast, Dr Ramli tells Editor-in-Chief of Injury Prevention, Rod McClure, how she stepped from the operating theatre to research, and into public health policy. 
Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!

Helmet type, road safety, covid-19 lockdowns. An oromaxillofacial surgeon preventing injuries in KL

In this second podcast focussing on the covid response in South Asia, we’re focussing on the intersection of conflict and covid in the region. The pandemic has highlighted the underlying weaknesses in many health systems - but could it also be used as a catalyst for change, and be a step towards easing tensions?

To discuss this,  Kamran Abbasi, executive editor of The BMJ, is joined by Zulfiqar Bhutta, head of the Institute for Global Health and Development, Aga Khan University, and Arun Mitra senior vice president of Indian Doctors for Peace & Development.

To read more;
Conflict, extremism, resilience and peace in South Asia; can covid-19 provide a bridge for peace and rapprochement?
https://www.bmj.com/content/375/BMJ-2021-067384

Covid and conflict In South Asia

In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Ramesh Nadarajah from the University of Leeds. They discuss their recent paper on Covid-bloated waiting lists and whether modelling can help to improve the situation for patients with aortic stenosis. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://bmjopen.bmj.com/content/12/6/e059309

BMJ's Coronavirus (COVID-19) playlist

BMJ talk medicine